EcoDrugPlus

Ensembl ID : ENSPVAG00000000184
Gene Symbol: -
Cross references: -
89 Possible Orthologues:

Ensembl ID : ENSPVAG00000008455
Gene Symbol: -
Cross references: -
213 Possible Orthologues:

Ensembl ID : ENSPVAG00000008974
Gene Symbol: -
Cross references: -
440 Possible Orthologues:

Ensembl ID : ENSPVAG00000001108
Gene Symbol: -
Cross references: -
330 Possible Orthologues:

Ensembl ID : ENSPVAG00000001287
Gene Symbol: -
Cross references: -
165 Possible Orthologues:

Ensembl ID : ENSPVAG00000003088
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSPVAG00000000289
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSPVAG00000017796
Gene Symbol: -
Cross references: -
243 Possible Orthologues:

Ensembl ID : ENSPVAG00000014168
Gene Symbol: -
Cross references: -
272 Possible Orthologues:

Ensembl ID : ENSPVAG00000014111
Gene Symbol: -
Cross references: -
118 Possible Orthologues:

Ensembl ID : ENSPVAG00000013840
Gene Symbol: -
Cross references: -
264 Possible Orthologues:

Ensembl ID : ENSPVAG00000010668
Gene Symbol: -
Cross references: -
135 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).